Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
161 participants
OBSERVATIONAL
2007-03-31
2010-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Observational Study of Disease Severity in Participants Diagnosed With Crohn's Disease and Long Term Impact of Treatment Strategies in Participants With Moderate to Severe Crohn's Disease (Protocol P06484)
NCT01218360
Preventing Postoperative Relapse in Crohn's Disease Patients at Risk: Azathioprine Versus Mesalazine
NCT00946946
Observational Prospective Study to Identify Intestinal Microbial Profiles in Newly Diagnosed Crohn's Disease Patients
NCT06324591
The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active "Drug: Crohn's Disease"
NCT00245505
Detecting Postoperative Recurrence in Crohn's Disease
NCT00886327
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Crohn's disease
Patients with initially diagnosed Crohn's disease
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* written informed consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ferring Pharmaceuticals
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ferring Pharmaceuticals
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Development Support
Role: STUDY_DIRECTOR
Ferring Pharmaceuticals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Investigational Site, Ehrenfelsstraße 47
Berlin, , Germany
Investigational Site, Möllendorfstraße 111
Berlin, , Germany
Investigational Site, Graseggerstraße 105
Cologne, , Germany
Investigational Site, Münchner Straße 64
Dachau, , Germany
Investigational Site, Karlsbader Straße 7
Dinkelsbühl, , Germany
Investigational Site, Heiligengrabstraße 16
Hof, , Germany
Investigational Site, Am Tiefen Weg 2
Karlstadt am Main, , Germany
Investigational Site, Erdbeerfeld 8
Kiel-Altenholz, , Germany
Investigational Site, Hohenfelder Straße 20
Koblenz, , Germany
Investigational Site, Funkenburgstraße 19
Leipzig, , Germany
Investigational Site, Franz-Kail-Straße 2
Leverkusen, , Germany
Investigational Site, Bahnhofplatz 2
Mainz, , Germany
Investigational Site, Uferstraße 3
Minden, , Germany
Investigational Site, Hammer Straße 95
Münster, , Germany
Investigational Site, Weiltinger Str. 11
Nuremberg, , Germany
Investigational Site, Marktplatz 23
Rottenburg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FE 999907 (Pentasa)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.